3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia
This study is completed in the United States, in Bulgaria, in Czechia, .... It focuses on schizophrenia.
In United States
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States, in Bulgaria, in Czechia, .... It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It is testing drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, for Eating disorders.
In United StatesThis study is completed in the United States, in the United Kingdom, and in Russia. It is testing ABT-126 for schizophrenia.
In United StatesThis study is completed in the United States, in Bulgaria, in China, .... It is testing bitopertin for schizophrenia.
In United StatesThis study is completed in the United States. It is testing SAGE-547 for depression.
In United StatesThis study was terminated in the United States. It is testing efficacy, Safety, and Tolerability of Darigabat for Anxiety.
In United StatesThis study was withdrawn in the United States. It is testing iloperidone for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing Iloperidone Long-acting Injection (LAI) for schizophrenia.
In United StatesThis study is active but not recruiting in the United States. It is testing mazdutide Compared With Placebo for Addiction.
In United StatesThis study is completed in the United States. It is testing multiple Oral Doses of Luvadaxistat for schizophrenia.
In United StatesThis study is enrolling by invitation in the United States. It is testing primary Care Treatment for Eating disorders.
In United StatesThis study is completed in the United States, in Bulgaria, in Czechia, .... It is testing RL-007 for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.